中
EN
HOME
About Us
Technology
Partnership
Product & Service
Newsroom
Join Us
Contact Us
Newsroom
Activities
Industry News
Contact Us
Tel:
+86-20-22211450
Fax:
+86-20-22211445
Add:
2 Jinfengyuan China,510663
Activities
HOME
>
Newsroom
>
Activities
10
2024-04
XlifeSc Showcases New Cancer Immunotherapy Strategy at 2024 AACR Annual Meeting
9
2023-08
Major Publication: China's First TCR-T Product Phase I Clinical Research Results
10
2022-07
China’s First TCR-T Cell Therapy Asset Officially Commences Phase II Clinical Trials
10
2022-06
Tumor Response Rate (ORR) Reaches 41.7%! XLifeSc TCR-T Cell Therapy's Chinese Clinical Data Presented at ASCO 2022
/1
2020-01
Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell Therapy in Taiwan
more
Technology
|
Join Us
|
Newsroom
|
Contact Us
粤ICP备17063615号
Copyright © 2018 广东香雪精准医疗技术有限公司 All Rights Reserved
Powered by vancheer